The most common mechanisms promoting constitutive NRF2 activation are LOF mutations of KEAP1 and GOF mutations of NFE2L2 [74], which are frequently found in NSCLC sub-types [10,95] (see Section 3.2). The gene discussed is KEAP1; the disease is non-small cell lung carcinoma.